Skip to main content
Health and social care

Policy papers and consultations

Skip to results
1,665 results sorted by Updated (newest)
  • A national plan for NHS dentistry services in England.

    First published during the 2022 to 2024 Sunak Conservative government

  • This consultation seeks views on proposed amendments to the Health Protection (Notification) Regulations 2010 (HPNR).

    First published during the 2022 to 2024 Sunak Conservative government

  • We are seeking views on proposed changes in relation to nutrition labelling, composition and standards (NLCS) retained EU law.

    First published during the 2022 to 2024 Sunak Conservative government

  • We are seeking views on the proposed Disability Action Plan and the new areas for action it includes. We want to hear from as many people as possible.

    First published during the 2022 to 2024 Sunak Conservative government

  • The Disability Action Plan sets out the immediate actions the government will take in 2024 to improve disabled people’s everyday lives and lays the foundations for longer-term change.

    First published during the 2022 to 2024 Sunak Conservative government

  • Describes the working relationship between the Department of Health and Social Care and the Health Services Safety Investigations Body.

    First published during the 2022 to 2024 Sunak Conservative government

  • This consultation collected views on expanding the use of naloxone. It ran for 8 weeks and was open to all interested individuals and organisations.

    First published during the 2019 to 2022 Johnson Conservative government

  • The government is seeking views on the benefits and challenges of a separate pay spine for nursing staff.

    First published during the 2022 to 2024 Sunak Conservative government

  • We want to find out what skills and experience you think are important for adult social care staff.

    First published during the 2022 to 2024 Sunak Conservative government

  • We want your views on what should be included within a new care workforce pathway for adult social care.

    First published during the 2022 to 2024 Sunak Conservative government

  • The Advisory Council on the Misuse of Drugs (ACMD) seeks to gather insight into current government-led drug prevention policies and landscape across the UK.

    First published during the 2022 to 2024 Sunak Conservative government

  • UK NSC consulted on whether providers can safely use digital pathology as an alternative to light microscopy in examination of NHS cancer screening samples.

  • This is a consultation on a statutory instrument to amend the Human Medicines Regulations 2012 to remove the provision which provides the legal basis to the European Commission Decision Reliance Procedure (ECDRP).

  • This consultation will inform the government's proposed development of secondary legislation on visiting in care homes, hospitals and hospices.

    First published during the 2022 to 2024 Sunak Conservative government

  • The Advisory Council on the Misuse of Drugs call for evidence, collecting written evidence to better understand internet-facilitated drug markets (IFDMs).

    First published during the 2022 to 2024 Sunak Conservative government

  • Seeks views on the proposal to remove the statutory requirement for a full employment history when appointing volunteers in health and care settings.

    First published during the 2022 to 2024 Sunak Conservative government

  • A review that examines the risks of modern slavery within NHS supply chains and provides recommendations to mitigate these risks.

    First published during the 2022 to 2024 Sunak Conservative government

  • An agreement between DHSC, NHS England and ABPI to support patient access to medicines, the financial sustainability of the NHS and the UK life sciences sector.

    First published during the 2022 to 2024 Sunak Conservative government

  • We want your views on the revision of 13 existing EALs.

  • The MHRA is reviewing its approach to engagement with healthcare professionals to improve the safety of medicines and medical devices.